Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study

Objective: To study the incidence rate of juvenile idiopathic arthritis (JIA) and its clinical subtypes in Estonia, to follow the course of the disease in newly diagnosed patients for 2 years, and to find the frequency of human leucocyte antigens (HLA) B27, DR1 and DR4 in JIA patients. Method: A population-based study involving prospective registration of new cases of JIA in 1998–2000 and their clinical follow-up for 2 years. Results: In 1998–2000, 162 new cases of JIA were diagnosed. The mean annual incidence rate of JIA was 21.7 per 100 000 children aged 0–15 years (22.9 in girls and 19.3 in boys). During the investigation period, the incidence rate rose 3.5-fold. Oligoarthritis was the most frequent subtype (mean annual incidence rate of 11.7 per 100 000), followed by seronegative polyarthritis (4.4 per 100 000). HLA-DR1, B27 and DR4 were found respectively in 44.4, 28.6 and 11.1% of cases in which the analysis was performed. In HLA-B27-positive patients, inflammation markers of blood remained at a high level for a longer period compared with HLA-B27-negative patients. Conclusions: This is the first population-based study on the epidemiology of juvenile arthritis in Estonia in which the new classification criteria defined by the International League of Associations for Rheumatology (ILAR) have been used. In addition to environmental factors, an increase in awareness among family doctors is a probable reason for the rise in incidence during the study period. HLA-B27 might have predictive value as a marker of chronicity of inflammation.

[1]  Y. Lau,et al.  Anti‐cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population , 2005, Scandinavian journal of rheumatology.

[2]  B. Chiang,et al.  Factors affecting clinical and therapeutic outcomes of patients with juvenile rheumatoid arthritis , 2004, Scandinavian journal of rheumatology.

[3]  M. Suarez‐Almazor,et al.  International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .

[4]  Justine R. Smith,et al.  Arthritis and uveitis in children. A pediatric rheumatology perspective. , 2003, American journal of ophthalmology.

[5]  P. Manners,et al.  Worldwide prevalence of juvenile arthritis why does it vary so much? , 2002, The Journal of rheumatology.

[6]  A. T. Berk,et al.  Uveitis in juvenile arthritis , 2001, Ocular immunology and inflammation.

[7]  H. Huppertz,et al.  Cardiac Manifestations in Patients with HLA B27-Associated Juvenile Arthritis , 2000, Pediatric Cardiology.

[8]  M. Suarez‐Almazor,et al.  Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. , 1998, The Journal of rheumatology.

[9]  S. Gabriel,et al.  Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing? , 1996, Arthritis and rheumatism.

[10]  O. Kaipiainen-Seppänen,et al.  Incidence of chronic juvenile rheumatic diseases in Finland during 1980-1990. , 1996, Clinical and experimental rheumatology.

[11]  C. Fink Proposal for the development of classification criteria for idiopathic arthritides of childhood. , 1995, The Journal of rheumatology.

[12]  A. Fasth,et al.  Epidemiology of juvenile chronic arthritis in southwestern Sweden: a 5-year prospective population study. , 1992, Pediatrics.

[13]  P. Woo,et al.  Increased frequency of DR4 in systemic onset juvenile chronic arthritis. , 1992, Clinical and experimental rheumatology.

[14]  I. Kunnamo,et al.  Incidence of arthritis in urban Finnish children. A prospective study. , 1986, Arthritis and rheumatism.

[15]  E. Albert,et al.  [Differentiation of juvenile chronic arthritis--diagnostic significance of HLA associations]. , 1984, Klinische Padiatrie.

[16]  J. Baum,et al.  Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. , 1977, Arthritis and rheumatism.

[17]  H. Kautiainen,et al.  HLA B27: A prognostic factor in juvenile chronic arthritis , 2005, Clinical Rheumatology.

[18]  B. Andersson Gäre,et al.  Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. , 2003, The Journal of rheumatology.

[19]  M. Rygg,et al.  Epidemiology of juvenile chronic arthritis in northern Norway: a ten-year retrospective study. , 1998, Clinical and experimental rheumatology.

[20]  E. Thorsby,et al.  HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. , 1983, Arthritis and rheumatism.

[21]  Jerry C. Jacobs Juvenile Rheumatoid Arthritis , 1993 .